Navigation Links
Global Implantable Drug Delivery Devices Market - New Industry Research Report Published by Transparency Market Research
Date:3/9/2013

Albany, New York (PRWEB) March 09, 2013

A growing prevalence of target disease segments such as prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, a rising global prevalence of unwanted pregnancies and a rapidly aging global population are some of the most impact rendering drivers for the global implantable drug delivery devices market.

Some of the other drivers for the market include government and NGO initiatives undertaken to promote contraceptive drug delivery implants, rising number of interventional cardiologists and the rising demand for minimally invasive surgeries. Introduction of biodegradable implantable drug delivery technologies and new products such as MicroChips catering to disease segments such as osteoporosis will serve the market as future growth opportunities.

Related Report : Bio-Implants Market
http://www.transparencymarketresearch.com/bio-implants-market.html

The market for implantable drug delivery devices in cardiovascular applications held majority of the market share in 2011 and owing to the introduction of bio-absorbable stents expected in 2014, its market share is likely to witness further increase by 2018. The biodegradable drug delivery implant technology will grow at a faster CAGR in comparison to the non-biodegradable drug delivery implant technology due to the fact that they do not involve re-surgeries for device removal and eliminates side effects induced by the prolonged presence of the device in the body.

Browse the full report at http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

The North American implantable drug delivery devices market held majority of the market share in 2011. However, its market share is expected to drop by 2018 owing to the accelerated market growth in the Asian regions induced by the economic development of emerging nations with high unmet medical needs such as India and China.

Browse All Market Research Reports : http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/3/prweb10497409.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Acrylonitrile Butadiene Styrene Market (ABS) - New Industry Research Report Published by Transparency Market Research
2. EtQ to Host Life Science Summit on the World of Quality and Global Supply Chain
3. Atlantica Group LLC to Support Global Business Incubation and "Soft Landing" Efforts
4. Infotrieve Hires Mary Ging, Global Publishing Expert, to Lead EU Office
5. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
6. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
7. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
8. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
9. Rapidly Growing Company Extends Global Reach
10. Enterprise Mobility players NuWare & VeliQ form a global partnership to deliver mPaaS solutions
11. Mylan to Acquire Agila to Create Leading Global Injectables Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... 22, 2017 , ... AESKU.GROUP, an innovation leader in ... Technologien GmbH, thereby expanding its product portfolio to include allergy and food intolerance ... atopic eczema or a food allergy. Allergies are escalating to epidemic proportions and ...
(Date:6/22/2017)... ... 2017 , ... RURO, Inc., a leading LIMS, RFID, and ... update to the Limfinity® framework. , LimitLIS® and other RURO solutions based on ... customers among labs and other businesses. Limfinity® 6.5 adds new features and improvements ...
(Date:6/20/2017)... Pa. , June 20, 2017  Kibow Biotech ... pleased to announce the issuance of a new patent ... or hyperuricemia by the U.S. Patent and Trademark Office ... a winner of the Buzz of Bio award in ... is akin to developing non-drug approaches to chronic disease. ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... solutions for clinical development reported today that it is launching two new additions ... company will be demonstrating new capabilities at the DIA 2017 Annual Meeting in ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):